Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-30

Clinical Trial Update: RIXUBIS PMS India (RIXUBIS PMS) [Phase 4]

View source ↗

Summary

Phase 4 trial update for RIXUBIS in Hemophilia B; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RIXUBIS (recombinant coagulation factor IX)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Hemophilia B | Phase 4 | Status: COMPLETED | Results posted: 2022-08-30